MYGN Financial Facts

Selling, general, and administrative expense: 91.3M
Total costs and expenses: 150.8M
See Full Income Statement

Total stockholders' equity: -1.48B
Net equipment and leasehold improvements: 58.3M
See Full Balance Sheet

Myriad Genetics Inc. (MYGN) Earnings

  |   Expand Research on MYGN
Next EPS Date 11/3/16 *Est. EPS Growth Rate -22.0% *Last Qtr.
Average EPS % Beat Rate +4.8% Revenue Growth Rate -1.8% *Last Qtr.
Average % Move 1-Wk after EPS -8.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/9/16 Q416 $0.32$0.38 -$0.06$186.5M$187.92M = Details
5/3/16 Q316 $0.41$0.38 +$0.03$190.5M$184.92M = Details
2/2/16 Q216 $0.45$0.41 +$0.04$193.3M$189.97M = Details
11/3/15 Q116 $0.41$0.35 +$0.06$183.5M$177.89M = Details
8/11/15 Q415 $0.41$0.42 -$0.01$189.9M$187.77M = Details
5/5/15 Q315 $0.40$0.39 +$0.01$180M$183.3M = Details
2/3/15 Q215 $0.40$0.35 +$0.05$184.4M$183.41M = Details
11/4/14 Q115 $0.25$0.32 -$0.07$168.8M$175M = Details